Lineage Cell Therapeutics
LCTX
#8743
Rank
ยฃ94.48 M
Marketcap
ยฃ0.43
Share price
-1.91%
Change (1 day)
-51.48%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ26.06 Million

According to Lineage Cell Therapeutics 's latest financial reports the company has ยฃ26.06 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ27.85 M-41.77%
2022-12-31ยฃ47.83 M10.65%
2021-12-31ยฃ43.23 M41.79%
2020-12-31ยฃ30.49 M30.17%
2019-12-31ยฃ23.42 M-3.28%
2018-12-31ยฃ24.21 M-14.26%
2017-12-31ยฃ28.24 M53.44%
2016-12-31ยฃ18.4 M-36.53%
2015-12-31ยฃ29 M53.13%
2014-12-31ยฃ18.94 M468.54%
2013-12-31ยฃ3.33 M23.79%
2012-12-31ยฃ2.69 M-81.17%
2011-12-31ยฃ14.29 M-33.8%
2010-12-31ยฃ21.58 M186.59%
2009-12-31ยฃ7.53 M89807.02%
2008-12-31ยฃ0 M75.18%
2007-12-31ยฃ0 M-98.33%
2006-12-31ยฃ0.28 M-73.07%
2005-12-31ยฃ1.06 M48.93%
2004-12-31ยฃ0.71 M78.09%
2003-12-31ยฃ0.4 M-49.95%
2002-12-31ยฃ0.8 M-29.73%
2001-12-31ยฃ1.13 M29.05%
2000-12-31ยฃ0.88 M-73.03%
1999-12-31ยฃ3.27 M126.95%
1998-12-31ยฃ1.44 M
1998-06-30ยฃ2.45 M-47.58%
1997-06-30ยฃ4.68 M203.43%
1996-06-30ยฃ1.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.21 B 732.65%๐Ÿ‡บ๐Ÿ‡ธ USA